Diagnostic and symptomatic breast imaging is what this system serves, across standard mammographic views with tomosynthesis and guided biopsy available where licensed and configured. All clinical judgement, including whether an examination or procedure is indicated, how findings are interpreted and how a service structures its pathways, remains with the clinicians and the programme concerned, and Medigear.uk supplies configuration and condition detail rather than clinical guidance.
Assessment of findings raised on prior imaging is where the combination of tomosynthesis and biopsy capability contributes most, since characterisation and sampling can proceed on the same equipment rather than across separate appointments.
Denser breast tissue is where superimposition is greatest and where slice reconstruction addresses the limitation most directly, though the clinical role of the technique in any given pathway is a matter for the service.
Symptomatic clinics benefit from completing more of the pathway in a single attendance, which shortens the interval between a finding and an answer.
Services considering screening use should establish the applicable programme requirements before purchase, since organised screening carries specific equipment and quality assurance conditions beyond the general regulatory position.
Departments assessing capacity should note that a room capable of biopsy absorbs work that would otherwise be referred, which changes both its utilisation and the pathway around it.